Literature DB >> 4349722

Prostaglandin E2: effects on aggregation, shape change and cyclic AMP of rat platelets.

H Shio, P W Ramwell, S J Jessup.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4349722     DOI: 10.1016/0090-6980(72)90063-9

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


× No keyword cloud information.
  6 in total

1.  PGE2 decreases reactivity of human platelets by activating EP2 and EP4.

Authors:  James P Smith; Elias V Haddad; Jason D Downey; Richard M Breyer; Olivier Boutaud
Journal:  Thromb Res       Date:  2010-05-08       Impact factor: 3.944

2.  The effect of peroxidized arachidonic acid upon human platelet aggregation.

Authors:  H S Mickel; J Horbar
Journal:  Lipids       Date:  1974-02       Impact factor: 1.880

3.  Heterogeneity of thromboxane A2 (TP-) receptors: evidence from antagonist but not agonist potency measurements.

Authors:  P M Tymkewycz; R L Jones; N H Wilson; C G Marr
Journal:  Br J Pharmacol       Date:  1991-03       Impact factor: 8.739

4.  Laropiprant attenuates EP3 and TP prostanoid receptor-mediated thrombus formation.

Authors:  Sonia Philipose; Viktoria Konya; Mirjana Lazarevic; Lisa M Pasterk; Gunther Marsche; Sasa Frank; Bernhard A Peskar; Akos Heinemann; Rufina Schuligoi
Journal:  PLoS One       Date:  2012-08-01       Impact factor: 3.240

Review 5.  E-type prostanoid receptor 4 (EP4) in disease and therapy.

Authors:  Viktoria Konya; Gunther Marsche; Rufina Schuligoi; Akos Heinemann
Journal:  Pharmacol Ther       Date:  2013-03-21       Impact factor: 12.310

6.  Damage control: Harnessing prostaglandin E2 as a potential healing factor of tissue injuries.

Authors:  Connie Shao; Christine Shen; Emily Lu; Rex C Haydon; Hue H Luu; Aravind Athiviraham; Tong-Chuan He; Michael J Lee
Journal:  Genes Dis       Date:  2015-09-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.